David is an Associate in the Firm's Frankfurt office. He primarily advises on cross-border mergers, acquisitions and venture capital financings.
His practice consists of three pillars: German, US/UK and international M&A transactions.
David actively advises European corporate clients, fast growth companies, PE houses, and sovereign wealth funds in connection with cross-border mergers, acquisitions and venture capital financings. In his practice, he helps global clients navigate the intricacies of fundraising, investing and operating in the consumer discretionary, life sciences, robotics, and software industries.
Prior to joining White & Case, David gathered M&A experience as an associate in the Frankfurt office of an international law firm.
Qatar Investment Authority
Advised Qatar Investment Authority (QIA) on its participation in the (i) US$160 million Series C financing of Century Therapeutics, a leading cell therapy company headquartered in Philadelphia developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, (ii) US$116 million Series B financing of Entrada Therapeutics Inc., a privately-held biotechnology company dedicated to transforming the treatment of devastating diseases using intracellular biologics, and (iii) US$230 million Series B fundraising of Tessera Therapeutics, Inc., an early-stage life sciences company founded by Flagship Pioneering that is pioneering Gene Writing.
Advised Nestlé in connection with several transactions, including (i) the creation of a joint venture with Casa Tarradellas, with their respective stakes 40% and 60%, to include the Herta charcuterie (cold cuts and meat-based products) which is available in six European countries and the Herta dough business in France and Belgium, (ii) the sale and transfer by Nestlé Waters of all shares in a joint venture in Ethiopia to local partners, and (iii) the sale of its dairy and waters businesses in Uzbekistan to the France-based Lactalis group.
Advised ABB Limited, a global leader in smart buildings technology and solutions, in the acquisition of Dublin-headquartered Cylon Controls Limited, which provides building automation and HVAC control solutions through its operations in China, Germany, Ireland, the UK and the US.
Advised Panasonic Corporation on the German aspects of its 20% strategic equity investment in Blue Yonder, a leading US end-to-end supply chain software provider with an estimated enterprise value of US$5.5 billion.
Advised Easyfairs on (i) the acquisition of Stuttgart-based Untitled Exhibitions GmbH, whose portfolio of events includes All About Automation, four regional trade fairs focused on industrial automation, and (ii) the acquisition of Clarion Events Deutschland GmbH, a leading organizer of industrial trade shows in the mechanical engineering industry in Germany.
Advised Alder Fund I AB on the sale of Gasmet Technologies Oy to Nederman Holding AB as well as the preceding acquisition by Gasmet Technologies Oy of Austria-based MonitoringSystems GmbH.
Brookfield Infrastructure and its institutional partners and GIC
Advised a consortium composed of Brookfield Infrastructure and its institutional partners and GIC, Singapore's sovereign wealth fund, on the German aspects of the US$8.4 billion acquisition of Genesee & Wyoming Inc., a freight railroad owner and operator based in the United States.
Advised Hassan Allam Holding, a leading construction and engineering group headquartered in Cairo, Egypt in its indirect acquisition of a majority interest in Bioworks AG, a global leader in waste water treatment engineering based in Munich, Germany with subsidiaries in the US and Morocco.
Canon Medical Systems
Advised Canon Medical Systems Corporation, a Japanese medical equipment company, in its acquisition of Skope Magnetic Resonance Technologies AG, a Swiss company specializing in data processing and image reconstruction for magnetic resonance imaging (MRI).
Advised the Elekta group on various corporate and commercial matters.*
* Matters prior to working for White & Case.